Abstract:Monoclonal antibody (mAb)-based drugs are critical anti-cancer therapies. Unfortunately, therapeutic efficacy can be compromised by spatially heterogeneous intratumoral Ab deposition. Binding-site barriers arising from Ab and tumor-associated kinetics often underlie this phenomenon. Quantitative insight into these issues may lead to more efficient drug delivery. Difficulties in addressing this issue include (1) lack of techniques to quantify critical kinetic events, (2) lack of a pharmacokinetic/pharmacodynamic (PK/PD) model to assess important parameters for specific tumor types, and (3) uncertainty or variability of critical kinetic factors even within a single tumor type. This study developed a mechanism-based PK/PD model to profile heterogeneous distribution of Ab within tumors and tested this model using real-life experimental data. Model simulations incorporating several uncertainties were used to determine how mAb and tumor-associated kinetics influence receptor occupancy. Simulations were also used to predict the potential impact of these findings in preclinical tumor models and human tumors. We found significant differences in tumor-associated kinetics between groups in which mAb therapy was effective versus groups in which it was ineffective. These kinetic differences included rates of tumor-associated antigen (TAA) degradation, TAA expression, apparent flow rates of interstitial fluid, and ratios of Ab-TAA complex internalization to TAA degradation. We found less significant differences in mAb kinetics, including rates of clearance or affinity for target antigens. In conclusion, our mechanism-based PK/PD model suggests that TAA-associated kinetic factors participate more significantly than those associated with the Ab in generating barriers to mAb delivery and distribution in tumors.

In Situ Drug-Receptor Binding Kinetics in Single Cells: a Quantitative Label-Free Study of Anti-Tumor Drug Resistance

A Proteomic Landscape of Pharmacologic Perturbations for Functional Relevance

A multiparametric fluorescent visualization approach for detecting drug resistance in living cancer cells

Label‐Free Detection and Translocation Dynamics Study of Single‐Molecule Herceptin Using Solid‐State Nanopores

Analyze Impact of Tumor-Associated Kinetics on Antibody Delivery in Solid Tumors with a Physiologically Based Pharmacokinetics/pharmacodynamics Model.

Ultra-stable Biomembrane Force Probe for Accurately Determining Slow Dissociation Kinetics of PD-1 Blockade Antibodies on Single Living Cells.

Label-Free Quantification of Molecular Interaction in Live Red Blood Cells by Tracking Nanometer Scale Membrane Fluctuations.

Single-Cell Diagnosis of Cancer Drug Resistance through the Differential Endocytosis of Nanoparticles between Drug-Resistant and Drug-Sensitive Cancer Cells

Revealing Chemical Processes and Kinetics of Drug Action Within Single Living Cells Via Plasmonic Raman Probes

Exploration of drug resistance mechanisms in triple negative breast cancer cells using a microfluidic device and patient tissues

Quantification of Epidermal Growth Factor Receptor Expression Level and Binding Kinetics on Cell Surfaces by Surface Plasmon Resonance Imaging

Quantitative Study of the Drug Efflux Kinetics from Sensitive and MDR Human Breast Cancer Cells

Quantifying Imaging Agent Binding and Dissociation in 3-D Cancer Spheroid Tissue Culture Using Paired-Agent Principles

Nanotherapeutic approaches to overcome distinct drug resistance barriers in models of breast cancer

Characterizing heterogeneous single-cell dose responses computationally and experimentally using threshold inhibition surfaces and dose-titration assays

In Vitro Anticancer Drug Sensitivity Sensing Through Single-Cell Raman Spectroscopy

Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast Cancer

Circumventing Drug Resistance Pathways with a Nanoparticle-Based Photodynamic Method

Microfluidic chip for synergic drugs assay in 3D breast cancer cell

Single-Cell Analysis Of Signaling Proteins Provides Insights Into Proapoptotic Properties Of Anticancer Drugs

Simultaneous Quantification Of Protein Binding Kinetics In Whole Cells With Surface Plasmon Resonance Imaging And Edge Deformation Tracking